Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatments.

Abstract

BACKGROUND:

Gastrointestinal bleeding is a rare but severe complication of pancreatic ductal adenocarcinoma.

OBJECTIVE:

The purpose of this study was to describe the causes and treatments of non-postoperative gastrointestinal bleeding in patients with pancreatic ductal adenocarcinoma, and explore the parameters associated with therapeutic effectiveness.

METHODS:

This was a single-centre observational retrospective study (2000-2017) with data collected from the prospectively coded diagnostic hospital's database system including patients with pancreatic ductal adenocarcinoma who had a gastrointestinal bleeding episode. Effectiveness of haemostatic treatment was assessed according to transfusion requirements and immediate and long-term haemostatic efficacy; the latter defined as no bleeding recurrence.

RESULTS:

The population included 72 patients with pancreatic ductal adenocarcinoma who had 94 episodes of gastrointestinal bleeding. The main causes of gastrointestinal bleeding were gastroduodenal tumour invasion (56.4%) and oesophageal variceal bleeding due to left-sided portal hypertension (19.1%). In cases of gastrointestinal bleeding caused by tumour invasion, the main treatment was therapeutic endoscopy (41.5%). Among patients who had gastrointestinal bleeding by tumour invasion treated by endoscopy or radiation therapy, haemostatic immediate efficacy rates were 70.6% and 100%, respectively. Bleeding recurrence rates were 35.3% and 25.0%, for patients treated by endoscopy or radiation therapy, respectively, for a first episode of gastrointestinal bleeding by tumour invasion. Transfusion requirements, before and after treatment, were not different in patients treated by haemostatic radiation therapy for gastrointestinal bleeding by tumour invasion compared to other treatments (odds ratio 0.3, 95% CI (0.06-1.59); p = 0.16). The median survival after all-cause gastrointestinal bleeding was 2.72 months (1.43-4.01).

CONCLUSION:

Gastroduodenal tumour invasion was the main cause of gastrointestinal bleeding in patients with pancreatic ductal adenocarcinoma; haemostatic radiation therapy is a potential interesting option for gastrointestinal bleeding treatment in this context.

• Authors: Lina Aguilera Munoz, Louis de Mestier, Hanah Lamallem, Bénédicte Jaïs, Frédérique Maire, Philippe Lévy, Vinciane Rebours, Pascal Hammel
• Journal: United European gastroenterology journal (United European Gastroenterol J) Vol. 8 Issue 9 Pg. 1106-1114 (11 2020) ISSN: 2050-6414 [Electronic] England
• PMID: 32615874 (Publication Type: Journal Article, Observational Study)

Topics

• Aged
• Blood Transfusion (statistics & numerical data)
• Carcinoma, Pancreatic Ductal (complications, mortality, therapy)
• Endoscopy, Gastrointestinal (statistics & numerical data)
• Female
• Gastrointestinal Hemorrhage (etiology, mortality, therapy)
• Hemostatic Techniques (statistics & numerical data)
• Humans
• Male
• Middle Aged
• Neoplasm Invasiveness
• Pancreatic Neoplasms (complications, mortality, therapy)
• Radiotherapy (methods)
• Recurrence
• Retrospective Studies
• Treatment Outcome